🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Linezolid is the second line agent in the treatment of MRSA and PRSP infect...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2016-11-01
Trial ID
NCT03126890
Previous studies have suggested that serum carotenoids may be associated wi...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2017-11-01
Trial ID
NCT03433092
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as fenretinide, work in differe...
Status
Completed
Location
Childrens Hospital Los Angeles
Start Date
2006-12
Trial ID
NCT00646230
Treatments Being Tested
This randomized, double-blind, placebo-controlled clinical study is designe...
Status
Recruiting
Location
San Francisco Research Institute
Start Date
2026-04-29
Trial ID
NCT07441083
Treatments Being Tested
RATIONALE: Studying samples of blood in the laboratory from patients with c...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2005-07
Trial ID
NCT00283608
Acute coronary syndrome is defined as myocardial infarction or ischemia as ...
Status
Completed
Location
Virginia Commonwealtlh University Health Systems
Start Date
2013-04
Trial ID
NCT02039882
RATIONALE: White button mushroom extract may stop or delay the recurrence o...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2008-06
Trial ID
NCT00709020
The goal of this proposal is to determine how cannabinoid use affects the t...
Status
Unknown
Location
University of Colorado Denver
Start Date
2022-09-01
Trial ID
NCT05520294
Treatments Being Tested
This pilot prospective study will investigate the role of microbiota and kn...
Status
Completed
Location
Centre Hospitalier Universitaire de Bordeaux
Start Date
2020-05-14
Trial ID
NCT04272307
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-05-15
Trial ID
NCT02722668
Treatments Being Tested